Skip to main content

Table 1 Clinical characteristics of 5-year survivors of acute lymphoblastic leukemia

From: Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study

 

ALL survivors

Chemotherapy only

CRT

TBI

n = 213

%

n = 104

%

n = 95

%

n = 14

%

Age at diagnosis

        

  <5 yrs

111

52.1

61

58.7

45

47.4

5

35.7

  5-9 yrs

71

33.3

34

32.7

33

34.7

4

28.6

  10-17 yrs

31

14.6

9

8.7

17

17.9

5

35.7

Period of diagnosis

        

  1970-1979

42

19.7

3

2.9

39

41.1

0

0

  1980-1989

78

36.6

39

37.5

32

33.7

7

50.0

  1990-1999

93

43.7

62

59.6

24

25.3

7

50.0

Age at end of follow-up

        

  10-19 yrs

54

25.4

46

44.2

6

6.3

2

14.3

  20-29 yrs

71

33.3

39

37.5

26

27.4

6

42.9

  30-39 yrs

73

34.3

15

14.4

53

55.8

5

35.7

  >40 yrs

15

7.6

4

3.8

10

10.5

1

7.1

Relapse

24

11.3

2

1.9

11

11.6

11

78.6

Stem cell transplantation

14

6.6

0

0

0

0

14

100.0

Cranial irradiation

        

  12-15 Gy

2

0.9

  

2

2.1

0

0

  18 Gy

28

13.1

  

28

28.4

1

7.1

  20-23 Gy

6

2.8

  

6

6.3

0

0

  24-30 Gy

62

29.1

  

60

63.2

2

14.3

Total body irradiation

        

  8-12 Gy

14

6.6

    

14

100.0

  1. Abbreviations: ALL acute lymphoblastic leukemia, CRT received cranial irradiation in addition to chemotherapy, TBI received total body irradiation in addition to chemotherapy, including three cases who, in addition, received cranial irradiation.